- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03636802
Study of the Prevalence of Painful Symptoms of the Musculoskeletal System After Lung Transplantation
Study of the Prevalence, Nature and Contributing Factors of Painful Symptoms of the Musculoskeletal System After Lung Transplantation; Impact on Physical Activity and Quality of Life
Pulmonary transplantation (PT) is a therapeutic option now accepted in the management of selected patients who have reached the irreversible and terminal stage of their chronic respiratory insufficiency. Its main indications are: cystic fibrosis and other bronchial diseases, emphysema , interstitial lung diseases with idiopathic pulmonary fibrosis in the foreground, and severe pulmonary hypertension.
The evocation of osteo-articular and musculotendinous pain symptoms in the aftermath of PT is frequent and very diversified. These complications are poorly codified and hinder the rehabilitation and early resumption of physical activity and sports. Few data are available on this subject in the literature.
Following transplantation, improvements in respiratory function, quality of life, and exercise capacity are observed, with large inter-individual variations;
Patients are encouraged to resume physical activity, initially as part of a rehabilitation exercise.
Among the factors limiting exercise, some have been more widely studied, such as muscular deconditioning related to pre-existing chronic respiratory insufficiency , prolonged stay in intensive care, side effects of transplant-related treatments (corticosteroids and immunosuppressants).
Pain is also a factor limiting the recovery of physical activity and quality of life. Pain related directly to thoracotomy surgery has been explored but there is little data available on musculoskeletal pain.
The purpose of this study is to better understand the musculoskeletal pain occurring in the aftermath of a lung transplantation. Conducting this study for a period of 1 year will allow you to move away from the immediate post-transplant time, and the pain associated with the transplant will no longer have any interference.
The main objective of our study is to better know the prevalence of algic manifestations of the musculoskeletal system (osteo-articular, musculotendinous ...) occurring in the year following a TP, and may constitute a brake on the rehabilitation of the musculoskeletal system. effort and recovery of physical activity or sport.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pulmonary transplantation (PT) is a therapeutic option now accepted in the management of selected patients who have reached the irreversible and terminal stage of their chronic respiratory insufficiency. Its main indications are: cystic fibrosis and other bronchial diseases, emphysema (primary deficit or in the context of COPD), interstitial lung diseases with idiopathic pulmonary fibrosis in the foreground, and severe pulmonary hypertension.
The evocation of osteo-articular and musculotendinous pain symptoms in the aftermath of PT is frequent and very diversified. These complications are poorly codified and hinder the rehabilitation and early resumption of physical activity and sports. Few data are available on this subject in the literature.
Following transplantation, improvements in respiratory function, quality of life, and exercise capacity are observed, with large inter-individual variations.
Patients are encouraged to resume physical activity, initially as part of a rehabilitation exercise.
Among the factors limiting exercise, some have been more widely studied, such as muscular deconditioning related to pre-existing chronic respiratory insufficiency, prolonged stay in intensive care, side effects of transplant-related treatments (corticosteroids and immunosuppressants).
Pain is also a factor limiting the recovery of physical activity and quality of life. Pain related directly to thoracotomy surgery has been explored but there is little data available on musculoskeletal pain.
The purpose of this study is to better understand the musculoskeletal pain occurring in the aftermath of a lung transplantation. Conducting this study for a period of 1 year will allow you to move away from the immediate post-transplant time, and the pain associated with the transplant will no longer have any interference.
The main objective of our study is to better know the prevalence of algic manifestations of the musculoskeletal system (osteo-articular, musculotendinous ...) occurring in the year following a TP, and may constitute a brake on the rehabilitation of the musculoskeletal system. effort and recovery of physical activity or sport.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: PHILIPPE GIOVANNETTI
- Phone Number: +33 491366141
- Email: Philippe.GIOVANNETTI@ap-hm.fr
Study Locations
-
-
Paca
-
Marseille, Paca, France, 13354
- Recruiting
- Assistance Publique des Hôpitaux de Marseille
-
Contact:
- PHILIPPE GIOVANNETTI
- Phone Number: +33 491366141
- Email: Philippe.GIOVANNETTI@ap-hm.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient over 18
- Having agreed to no opposition
- Registered on the lung transplant waiting list of the CHU de Marseille
- Able to read, understand and complete the self-questionnaires of the study
Exclusion Criteria:
Patient under 18 years
- Patient refusing follow up until 12 months post transplant
- Pregnant women, persons deprived of their liberty, persons under guardianship or trusteeship, persons in an emergency situation
- Person not affiliated to a social security scheme or not entitled to
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
EXPERIMENTAL GROUP
Patient with respiratory failure and on a lung transplant waiting list
|
Brief Pain Inventory (BPI) This is a scale of self-assessment, the Concise Pain Questionnaire in French.
For all adult patients For any type of pain This is to ask the patient to answer questions in order to learn about us characteristics of his pain (its intensity and its repercussions on the plane biopsychosocial).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
numbers of patients with symptoms of the musculoskeletal system
Time Frame: 1 years
|
numbers of patients presenting symptoms of the musculoskeletal system during the study
|
1 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-48
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Insufficiency
-
Hospital Israelita Albert EinsteinRecruitingRespiratory Insufficiency in ChildrenBrazil
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenUnited Kingdom, Poland, Netherlands
-
Vyaire MedicalCompletedRespiratory Insufficiency in ChildrenNetherlands, Poland
-
Shanghai 10th People's HospitalUnknownPatients With Respiratory InsufficiencyChina
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationChina
-
Erasme University HospitalCentre Hospitalier Régional de la CitadelleNot yet recruitingRespiratory Insufficiency Requiring Mechanical VentilationBelgium
-
Fondazione Salvatore MaugeriAzienda Ospedaliero, Universitaria Pisana; Ataturk Training and Research HospitalCompletedChronic Respiratory InsufficiencyItaly
-
ADIR AssociationSuspendedCOPD | Chronic Respiratory InsufficiencyFrance
-
University Hospital, BordeauxCompletedRespiratory Failure | Acute Respiratory InsufficiencyFrance
-
Yolanda Lopez FernandezHospital Infantil Universitario Niño Jesús, Madrid, Spain; Dr. Negrin University... and other collaboratorsRecruitingAcute Respiratory InsufficiencySpain
Clinical Trials on Questionnaire BPI
-
Beta Pharma, Inc.Completed
-
Beta Pharma ShanghaiCompleted
-
Beta Pharma ShanghaiCompletedNon-small Cell Lung CancerChina
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingRenal Cell Carcinoma | Solid Tumor | Von Hippel-Lindau DiseaseChina
-
Xcovery Holding Company, LLCNot yet recruitingNon-small Cell Lung Carcinoma
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingA Phase 1 Study of BPI-371153 in Subjects With Advanced Solid Tumors or Relapsed/Refractory LymphomaLymphoma | HCC | NSCLC | Advanced Solid TumorChina
-
University of Texas Southwestern Medical CenterTerminated
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingColorectal Cancer | Pancreatic Cancer | Solid Tumor | Non-small Cell Lung CancerChina
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
Betta Pharmaceuticals Co., Ltd.Recruiting